To hear about similar clinical trials, please enter your email below

Trial Title: Dyadic Life Review Intervention for Older Patients with Advanced Cancer) and Their Caregivers

NCT ID: NCT06505122

Condition: Cancer

Conditions: Keywords:
Older Adults
Geriatric Oncology
Caregivers

Study type: Interventional

Study phase: N/A

Overall status: Not yet recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Behavioral
Intervention name: Dyadic Life Review
Description: DLR is an intervention that will promote relationship closeness, communication, and psychological distress in both older adults and caregivers.
Arm group label: Dyadic Life Review

Other name: DLR

Summary: The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial (RCT) comparing Dyadic Life Review (DLR) intervention in older adults with advanced cancer and their caregivers to Care-as-Usual (CAU) group, which involves a referral to social work.

Detailed description: The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial (RCT) comparing Dyadic Life Review (DLR) intervention in older adults with advanced cancer and their caregivers to Care-as-Usual (CAU) group, which involves a referral to social work. The study will enroll dyads (pairs) of caregivers and older patients with advanced cancer and dyads of caregivers and patients with advanced cancer. A previous single-arm study was performed testing the feasibility of the adapted DLR intervention in older adults with advanced cancer and their caregivers. The single-arm pilot demonstrated DLR was feasible and acceptable by both patients and caregivers. This innovative pilot study will gather data to test the feasibility of a pilot and examine pre-post intervention changes in caregiver psychological distress.

Criteria for eligibility:
Criteria:
Patient Inclusion Criteria: - Age ≥ 65 - Within 180 days of Stage III or IV advanced cancer diagnosis, any type of cancer - Score of 4 or more on National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT)* - Able to read and understand English Patient Exclusion Criteria: • Unable to identify caregiver to participate in study Caregiver Inclusion Criteria: - One caregiver for each patient will be eligible and must be chosen by the patient. For the purposes of this study, a caregiver is defined as a valued and trusted person in a patient's life who is supportive in health care matters by providing valuable social support and/or direct assistive care. - Caregivers will be selected by the patient when asked if there is a "significant other, spouse, or romantic partner with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") will remain eligible for the study. - Age 50 or older - Able to read and understand English Caregiver Exclusion Criteria: • Caregivers unable to provide consent

Gender: All

Minimum age: 50 Years

Maximum age: N/A

Healthy volunteers: No

Start date: November 1, 2024

Completion date: July 31, 2026

Lead sponsor:
Agency: University of Rochester
Agency class: Other

Source: University of Rochester

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06505122

Login to your account

Did you forget your password?